ISB (9702) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
10 Nov, 2026Executive summary
9M 2026 net sales rose 3.0% YoY to ¥28,562 million; operating profit increased 27.5% to ¥2,206 million and profit attributable to owners of parent rose 58.7% to ¥1,534 million.
Automotive plan revisions and spending cuts delayed embedded-systems projects; engineer redeployment to high-demand fields is accelerating ahead of Q4.
Financial highlights
Ordinary profit rose to ¥2,281 million from ¥1,752 million; gross profit increased to ¥6,925 million from ¥6,435 million, while SG&A was ¥4,718 million versus ¥4,705 million.
Basic EPS was ¥133.80, up from ¥84.44; comprehensive income rose to ¥1,502 million from ¥1,028 million.
Operating profit margin was 7.7%, up 150 bps from 6.2% in the prior-year period.
Outlook and guidance
FY2026 forecasts remain unchanged: net sales ¥38,500 million, operating profit ¥3,000 million, ordinary profit ¥3,050 million and net profit ¥1,850 million.
9M progress was 74.2% of sales, 73.5% of operating profit, 74.8% of ordinary profit and 82.9% of parent-attributable profit forecasts.
FY2026 basic EPS forecast is ¥161.40; Q4 priorities include redeploying engineers to non-automotive embedded fields and expanding medical and DX projects.
Latest events from ISB
- FY26 growth and a 2030 profit push underpin higher dividends.9702
Investor presentation - FY2030 targets pair higher profitability with people- and M&A-led growth and stronger returns.9702
Corporate presentation - Record 9M results continued a seven-period streak of revenue and profit growth.9702
Q3 2023 - H1 growth beat plan, led by Enterprise, with FY2023 targets maintained.9702
Q2 2023 - Record Q1 results across all four fields drove higher FY2023 guidance.9702
Q1 2023 - Record sales and operating profit; FY2024 guidance projects lower operating income.9702
Q4 2023 - Record Q1 results and strong DX demand prompted higher FY2024 guidance.9702
Q1 2024 - H1 earnings rose on DX and recurring-product demand; FY guidance forecasts lower profit.9702
Q2 2024 - Record 9M sales and profit; attributable profit rose 24.9%.9702
Q3 2024